Thrilled about our collaborative study now in eLife! New fundamental insights into what makes these promising compounds work #mitochondrialmedicine Structure-activity relationships of mitochondria-targeted tetrapeptide pharmacological compounds https://t.co/vfdaC3CJaF
Excited to share our latest work as a bioRxiv preprint, "Structure-Activity Relationships in the Design of Mitochondria-Targeted Peptide Therapeutics". Many thanks to an outstanding research team! https://t.co/yX1or0pV0j
Check out our new TiBS review written with good friend and colleague Steve Claypool. Congrats to Joseph Iovine on his first publication in the Alder Lab!
Mitochondrial compartmentalization: emerging themes in structure and function https://t.co/Rm1Madd8Bc
Excited to be part of this research in collaboration with the Rabinovitch, Marcinek and Szeto groups. Congrats to lead author Huiliang Zhang! Reduction of elevated proton leak rejuvenates mitochondria in the aged cardiomyocyte https://t.co/o4IXmQgYfM
Exciting new research from our group on the mechanism of mitochondrial therapeutic SS-31 (elamipretide)- preprint in bioRxiv https://t.co/8NBsgnV00f #mitochondria#mitomedicine
The risk of having a child affected with mitochondrial disease can be predicted, albeit within the limits of substantial variability, according to the proportion of mutant mitochondrial genomes carried by the mother. Learn more: https://t.co/ri5ck6mnOg #genetics